Gastrointestinal Cancer News

Researchers in the United Kingdom have launched a 2-year trial to evaluate whether a breath test can be used for early detection of multiple cancer types.

Results of a prospective study showed that treatment with direct-acting antivirals for hepatitis C correlated with significantly reduced risks for hepatocellular carcinoma and mortality, according to a study published in The Lancet.

Immune checkpoint inhibitor therapy appeared to be a safe, effective treatment for patients with advanced-stage cancer and HIV infection, according to a systematic review published in JAMA Oncology.

LAS VEGAS — In this exclusive video perspective from the Crohn’s & Colitis Congress 2019, Tonya Kaltenbach, MD, from the University of California San Francisco and the San Francisco Veteran’s Affairs Medical Center, discusses how using chromoendoscopy can improve colonoscopy screening in patients with inflammatory bowel disease.

Adults without family history, signs or symptoms of pancreatic cancer should not be screened for the disease, according to a draft recommendation issued by the U.S. Preventive Services Task Force.

Helicobacter pylori infection appeared associated with increased risk for colorectal cancer, particularly among African-Americans, according to study results.

Patients undergoing direct-acting antiviral therapy for hepatitis C who had non-characterized liver nodules had a higher risk for hepatocellular carcinoma within a short follow-up time than other patients, according to a recently published study.

Young adults in the U.S. demonstrated a higher risk for obesity-related cancers than previous generations, according to a study recently published in Lancet Public Health.

The FDA granted orphan drug designation to BL-8040 for the treatment of pancreatic cancer.

ASCO has named progress in treating rare cancers as the cancer Advance of the Year, recognizing major research advances that generated new treatments for patients with rare, difficult-to-treat cancers, such as desmoid tumors and uterine serous carcinoma, the society announced in a press release.